Academic literature on the topic 'Newborn screening'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Newborn screening.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Newborn screening"

1

Kayton, Allyson. "Newborn Screening: A Literature Review." Neonatal Network 26, no. 2 (March 2007): 85–95. http://dx.doi.org/10.1891/0730-0832.26.2.85.

Full text
Abstract:
Newborn screening is the largest genetic testing effort for newborns in the U.S. Its purpose is to identify newborns who are at risk for metabolic, endocrine, or hematologic disorders. A review of the literature was conducted to determine the benefits of newborn screening; specimen collection timing and handling; ethical considerations of screening; as well as current practices regarding consent, notification of results, and follow-up procedures. The use of tandem mass spectrometry for expanded newborn screening and postmortem diagnosis of unexplained infant death was also reviewed. This article is intended to educate health care providers in the areas of controversy that surround the U.S. newborn screening program, with the hope of encouraging further research in this important area of newborn care.
APA, Harvard, Vancouver, ISO, and other styles
2

Honzík, Tomáš, Viktor Kožich, Karolína Pešková, and Felix Votava. "Laboratory newborn screening." Česko-slovenská pediatrie 77, no. 1 (January 21, 2022): 12–18. http://dx.doi.org/10.55095/cspediatrie2022/002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wang, Yuanming, Chen Cheng, and Chuling Li. "Newborn hearing loss in the south of China: a cross-sectional study." Journal of International Medical Research 49, no. 12 (December 2021): 030006052110624. http://dx.doi.org/10.1177/03000605211062448.

Full text
Abstract:
Objective Newborn hearing screening can identify congenital deafness and hearing loss. The current status of newborn hearing screening in the south of China is unclear. We aimed to assess the hearing loss of newborns in Dongguan, China. Methods A total of 62,545 newborns were enrolled in this retrospective, cross-sectional study between September 2015 and August 2020. The screening procedure was carried out using a two-step hearing screening. The trends were examined by the Cochran–Armitage trend test. Results From 2015 to 2020, the total initial newborn hearing screening rate was 98.16%, and it significantly increased over time (Z = 2.488). The initial screening pass rate of newborns was 90.08%, and no significant difference was observed in the initial screening pass rate between different years (Z = 0.845). After two-step hearing screening, the overall hearing screening pass rate of newborns was 94.65%. The overall hearing screening pass rate in normal newborns was higher than that in high-risk newborns (95.70% vs. 93.59%). Conclusion The initial newborn hearing screening rate increased yearly in the study period, but there was still an approximately 10% referral rate. The initial screening pass rate in China needs to be further improved.
APA, Harvard, Vancouver, ISO, and other styles
4

Jones, David, Jianyin Shao, Heidi Wallis, Cody Johansen, Kim Hart, Marzia Pasquali, Ramkiran Gouripeddi, and Andreas Rohrwasser. "Towards a Newborn Screening Common Data Model: The Utah Newborn Screening Data Model." International Journal of Neonatal Screening 7, no. 4 (October 27, 2021): 70. http://dx.doi.org/10.3390/ijns7040070.

Full text
Abstract:
As newborn screening programs transition from paper-based data exchange toward automated, electronic methods, significant data exchange challenges must be overcome. This article outlines a data model that maps newborn screening data elements associated with patient demographic information, birthing facilities, laboratories, result reporting, and follow-up care to the LOINC, SNOMED CT, ICD-10-CM, and HL7 healthcare standards. The described framework lays the foundation for the implementation of standardized electronic data exchange across newborn screening programs, leading to greater data interoperability. The use of this model can accelerate the implementation of electronic data exchange between healthcare providers and newborn screening programs, which would ultimately improve health outcomes for all newborns and standardize data exchange across programs.
APA, Harvard, Vancouver, ISO, and other styles
5

Matteson, Jamie, Stanley Sciortino, Lisa Feuchtbaum, Tracey Bishop, Richard S. Olney, and Hao Tang. "Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up." International Journal of Neonatal Screening 7, no. 2 (April 17, 2021): 22. http://dx.doi.org/10.3390/ijns7020022.

Full text
Abstract:
X-linked adrenoleukodystrophy (ALD) is a recent addition to the Recommended Uniform Screening Panel, prompting many states to begin screening newborns for the disorder. We provide California’s experience with ALD newborn screening, highlighting the clinical and epidemiological outcomes observed as well as program implementation challenges. In this retrospective cohort study, we examine ALD newborn screening results and clinical outcomes for 1,854,631 newborns whose specimens were received by the California Genetic Disease Screening Program from 16 February 2016 through 15 February 2020. In the first four years of ALD newborn screening in California, 355 newborns screened positive for ALD, including 147 (41%) with an ABCD1 variant of uncertain significance (VUS) and 95 males diagnosed with ALD. After modifying cutoffs, we observed an ALD birth prevalence of 1 in 14,397 males. Long-term follow-up identified 14 males with signs of adrenal involvement. This study adds to a growing body of literature reporting on outcomes of newborn screening for ALD and offering a glimpse of what other large newborn screening programs can expect when adding ALD to their screening panel.
APA, Harvard, Vancouver, ISO, and other styles
6

Babac, Snezana, Dragoslava Djeric, and Zoran Ivankovic. "Newborn hearing screening." Srpski arhiv za celokupno lekarstvo 135, no. 5-6 (2007): 264–68. http://dx.doi.org/10.2298/sarh0706264b.

Full text
Abstract:
Introduction: Prevalence of sensorineural hearing loss is 1-3 per 1,000 newborns. Transient evoked otoacoustic emission (TEOAE) and automated auditory brain stem responses (AABR) are most frequently used methods in newborn hearing screening programmes. Objective. The aim of this study was to examine hearing function in newborns with and without risk factors for hearing loss. We investigated accuracy and feasibility of two automated technologies: transient otoacoustic emissions (TEOAE) and auditory brain stem response (AABR) in early detection of hearing loss. Method. In prospective study, 907 newborns were tested on both ears with transient evoked otoacoustic emissions (TEOAE). If results were "refer", we performed automated brain stem response (AABR). Two stage screening protocols were used with two screening technologies (TEOAE, AABR). Results. Results showed screening pass of 86.3% of the newborns in the first protocol and 99.3% in the second. Six (0.7%) newborns had positive screening results for hearing loss. They were referred for additional audolologic tests (otoacoustic emissions, tympanometry, and auditory brain stem response) to confirm or exclude hearing loss. Audiologic examination was performed up to the third month of life. We confirmed unilateral sensorineural hearing loss in two babies. Average test time per ear was 21.3?19.4 s for TEOAE and 135.3?67.9 s for AABR. Conclusion TEOAE, AABR tests are confidential, noninvasive and feasible methods and can help to detect hearing impairment.
APA, Harvard, Vancouver, ISO, and other styles
7

Rosenau, Henning, and Felicia Steffen. "Legal aspects of newborn screening." Medizinische Genetik 34, no. 1 (April 1, 2022): 3–11. http://dx.doi.org/10.1515/medgen-2022-2110.

Full text
Abstract:
Abstract Newborn screening is used for the early detection of diseases in newborns and enables rapid intervention to prevent serious consequences, including infant death. Since the Genetic Diagnostics Act came into force in 2010, the rules of the Act have applied to newborn screening. Over the years since the Act came into force, some legal issues have been resolved, but new legal aspects have also arisen for which the Act does not yet provide a solution.
APA, Harvard, Vancouver, ISO, and other styles
8

MK, Vybhavi, and Srinivas V. "Hearing Screening of Newborns using Distortion Product Otoacoustic Emissions." Bengal Journal of Otolaryngology and Head Neck Surgery 29, no. 2 (September 27, 2021): 189–95. http://dx.doi.org/10.47210/bjohns.2021.v29i2.478.

Full text
Abstract:
Introduction The present study was devised to estimate the prevalence of neonatal hearing loss and document the importance of using DPOAE as a screening tool for identifying hearing loss in newborns. Materials and Methods This hospital based descriptive study was conducted from August 2018 to August 2019. A total of 928 newborn babies were included in the study. These newborn babies were subjected to hearing screening by distortion product otoacoustic emissions (DPOAE) at 24-72 hrs after birth. For pass cases, no further testing was done. For refer cases, repeat testing with DPOAE was done within 15-30 days. Newborns with refer result on repeat DPOAE testing were subjected to Brainstem evoked response audiometry (BERA) within 3 months to confirm hearing loss. Results Nine hundred and twenty eight newborn babies were screened by DPOAE. 851 newborns passed the first DPOAE hearing screening and 77 newborns gave refer result. 21 newborns were lost to follow-up. 56 newborns underwent repeat DPOAE testing and 5 newborns were referred for BERA. Amongst the 5 newborns who underwent BERA testing, one newborn was diagnosed with bilateral profound hearing loss. Hence, the prevalence of hearing loss of 1.08 per thousand newborn babies was estimated in this study. Conclusion Hearing screening of newborns using DPOAE followed by BERA in refer cases to confirm hearing loss is useful for early detection followed by timely intervention and rehabilitation.
APA, Harvard, Vancouver, ISO, and other styles
9

Anderson, Rebecca, Erin Rothwell, and Jeffrey R. Botkin. "Newborn Screening." Annual Review of Nursing Research 29, no. 1 (December 2011): 113–32. http://dx.doi.org/10.1891/0739-6686.29.113.

Full text
Abstract:
Newborn Dried Blood Spot Screening (NBS) is a core public health service and is the largest application of genetic testing in the United States. NBS is conducted by state public health departments to identify infants with certain genetic, metabolic, and endocrine disorders. Screening is performed in the first few days of life through blood testing. Several drops of blood are taken from the baby's heel and placed on a filter paper card. The dried blood, on the filter cards, is sent from the newborn nursery to the state health department laboratory, or a commercial partner, where the blood is analyzed. Scientific and technological advances have lead to a significant expansion in the number of tests—from an average of 6 to more than 50—and there is a national trend to further expand the NBS program. This rapid expansion has created significant ethical, legal, and social challenges for the health care system and opportunity for scholarly inquiry to address these issues. The purpose of this chapter is to provide an overview of the NBS programs and to provide an in-depth examination of two significant concerns raised from expanded newborn screening, specifically false-positives and lack of information for parents. Implications for nursing research in managing these ethical dilemmas are discussed.
APA, Harvard, Vancouver, ISO, and other styles
10

Little, Cindy M., and Judith A. Lewis. "Newborn Screening." Newborn and Infant Nursing Reviews 8, no. 1 (March 2008): 3–9. http://dx.doi.org/10.1053/j.nainr.2007.12.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Newborn screening"

1

Araia, Makda. "Newborn Screening Education: A Survey of Ontario Mothers." Thesis, Université d'Ottawa / University of Ottawa, 2011. http://hdl.handle.net/10393/20333.

Full text
Abstract:
Purpose and methods: Effective parental education about newborn screening (NBS) may help to maximize the benefits and minimize the harms of screening. We investigated experiences, knowledge and opinions regarding NBS education among Ontario mothers. Mothers whose infants recently received NBS were invited to complete a mailed survey (n=1712). Results: Of the 750 participants, 93% recalled their infant receiving NBS, while 69% recalled receiving information about NBS. Of this group, fewer than 50% reported receiving information prenatally, yet a majority of mothers (64%) viewed this as the most important time for education. Those who received information prenatally reported higher satisfaction (OR 2.4). The 40% of mothers who recalled being informed about the meaning of results had higher knowledge about NBS (OR 2.7) and reported higher satisfaction (OR 4.2). Conclusions: Parental education about NBS could place greater emphasis on the prenatal period and on fostering understanding about the meaning of results.
APA, Harvard, Vancouver, ISO, and other styles
2

Rahman, Alvi. "Estimating Screening Results Following the Introduction of Next-generation Sequencing Into Newborn Screening." Thesis, Université d'Ottawa / University of Ottawa, 2017. http://hdl.handle.net/10393/36988.

Full text
Abstract:
Objective: The objective of this thesis was to estimate the impact on newborn screening (NBS) results of changing screening technology from tandem mass spectrometry (MS/MS) to an approach using targeted next-generation sequencing (T-NGS) and MS/MS in parallel. Methods: We integrated results of an analysis of MS/MS screening data for phenylketonuria (PKU) and medium-chain acyl-CoA dehydrogenase (MCAD) deficiency; and a query of genetic compendia for variants of genes associated with the two disorders. Results: The introduction of T-NGS into NBS may reduce nearly 80% of false positives that are generated using the current screening approach. Based on estimated NBS results, T-NGS may be applied using a second-tier approach, which may improve specificity while maintaining sensitivity at its current level. Discussion: T-NGS may enhance the performance of NBS for PKU by improving specificity when used as a second tier test, but may be limited by feasibility and cost under current circumstances. Future studies should consider the cost-effectiveness of T-NGS for all infants undergoing NBS.
APA, Harvard, Vancouver, ISO, and other styles
3

Buser, Karen N. Kamiri. "Parental Attitudes Regarding Newborn Screening for Duchenne Muscular Dystrophy." Case Western Reserve University School of Graduate Studies / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=case1307627473.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ossler, Sarah. "Attitudes and Beliefs toward Expanded Newborn Screening in Colombia." University of Cincinnati / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1399629916.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lai, Yoke Fei. "Comparison of screening protocols for congenital adrenal hyperplasia (CAH) in the New South Wales Newborn Screening Programme." Thesis, The University of Sydney, 2022. https://hdl.handle.net/2123/29574.

Full text
Abstract:
Congenital adrenal hyperplasia (CAH) is a group of disorders with autosomal recessive inheritance and an incidence approximately 1:14 000 to 1:18 000 worldwide. The NSW Newborn Screening Programme currently screens all newborns born in NSW and the ACT for salt-wasting CAH by measuring 17α-hydroxyprogesterone (17αOHP) level using immunoassay, followed by a second-tier liquid chromatography tandem mass spectrometry (LC-MS/MS) steroid profile. Any newborn with a calculated ratio of (17α-hydroxyprogesterone (MS17αOHP)+androstenedione(A4))/cortisol>2 or MS17αOHP concentration>200nmol/L is deemed screen positive with the current protocol and therefore requires referral for diagnostic testing and, if proven to have CAH, referred for management. In this study, three analytical techniques (fluoroimmunoassay, LC-MS/MS, and next generation sequencing using targeted variant analysis) were compared. As well, stratification of action limits for birthweight and gestational age, and for the LC-MS/MS assay additional steroids that could be measured on the same sample at the same time were evaluated to determine whether performance indicators could be improved. After assessing the screening efficacy, result notification time, and analytical cost for each method, immunoassay and LC-MS/MS remained the preferred screening methods at this time in comparison to NGS. This study conducted on dried blood spot samples received from May 2018 to Feb 2022 found that the use of a two-tier protocol using immunoassay as a first tier and LC-MS/MS as a second tier remained the optimal analytical protocol. There were 16 proven cases of CAH from 388 416 babies giving an observed incidence of 1:24 276. This study proposes using MS17αOHP action limit of 40.1nmol/L in combination with the ratios (MS17αOHP+A4)/cortisol of 1.2 and MS17αOHP/cortisol of 1.6 to detect SW CAH.
APA, Harvard, Vancouver, ISO, and other styles
6

Турова, Людмила Олександрівна, Людмила Александровна Турова, Liudmyla Oleksandrivna Turova, V. Petroshenko, and W. A. Alsaedi. "Modern Methods of neonatal screening." Thesis, Сумський державний університет, 2013. http://essuir.sumdu.edu.ua/handle/123456789/32305.

Full text
Abstract:
Neonatal screening is a program, which aims at early identification of conditions for which early and timely intervention can prevent or reduce associated mortality and morbidity. The most modern screening technology is the tandem mass spectrometry (tandem MS; MS/MS). MS/MS-newborn screening requires confirmatory testing and clinical evaluation before a diagnosis can be made. When you are citing the document, use the following link http://essuir.sumdu.edu.ua/handle/123456789/32305
APA, Harvard, Vancouver, ISO, and other styles
7

Daniels, Molly Serena. "PARENTS' KNOWLEDGE OF AND EXPERIENCES WITH THE OHIO NEWBORN SCREENING." University of Cincinnati / OhioLINK, 2002. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1029504389.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zuckerman, Shlomit. "The Expansion of Newborn Screening In Israel: Ethical and Social Dimensions." Cleveland, Ohio : Case Western Reserve University, 2009. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=case1247156923.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Frei, Julia. "The provision of newborn screening: A conjoint analysis of women's preferences." Thesis, University of Ottawa (Canada), 2007. http://hdl.handle.net/10393/27843.

Full text
Abstract:
Context. There has been increasing attention concerning the use of DNA-based genetic tests in health care. Many have argued that the use of genetic technologies should be subject to public debate and scrutiny. However, few in the general population can offer views informed by actual experience with genetic services. Prenatal and newborn screening programs are examples of genetic services that are routinely offered to the general population. Objectives. To determine if conjoint analysis is a useful tool for eliciting user preferences for newborn screening services. Methods. Discrete choice conjoint analysis (CA). Results. Counterintuitive results identified issues concerning the validity of the CA instrument that was developed. As a result limitations to the usefulness of aggregate logit regression for the analysis of CA data were identified. Other analytical approaches, such as latent class analysis, merit further examination to determine their validity and the value of the information they may provide.
APA, Harvard, Vancouver, ISO, and other styles
10

Spady, Donald William. "Who gets missed, coverage in the 1992 Alberta newborn screening program." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq21208.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Newborn screening"

1

Early Hearing Detection and Intervention Program (Or.)., ed. Newborn hearing screening. Portland, Or: Early Hearing Loss Detection & Intervention Program, Oregon Dept. of Human Services, Office of Family Health, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

G, Spivak Lynn, ed. Universal newborn hearing screening. New York: Thieme, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ian, Leck, and Wald Nicholas J, eds. Antenatal and neonatal screening. 2nd ed. Oxford: Oxford University Pres, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

J, Driscoll Carlie, and McPherson Bradley, eds. Newborn screening systems: The complete perspective. San Diego: Plural Pub., 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

E, Fornoff J., Illinois. Division of Epidemiologic Studies., and Centers for Disease Control and Prevention (U.S.), eds. Newborn metabolic screening in Illinois, 2005. [Springfield: Ill.], 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Division, Alberta Public Health. Newborn metabolic screening in Alberta 2002-2005. Edmonton: Public Health Division, Alberta Health and Wellness, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

State laws and regulations governing newborn screening. Chicago: American Bar Foundation, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Texas. Bureau of Children's Health. and Texas Bureau of Laboratories, eds. Texas newborn screening program: A practitioner's guide. Texas: The Bureau, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

T, Swigart Elca, ed. Neonatal hearing screening. Basingstoke: Taylor & Francis, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

1939-, Swigart Elca T., ed. Neonatal hearing screening. San Diego, Calif: College-Hill Press, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Newborn screening"

1

DeTolve, Geoffrey R. "Newborn Screening." In Health Care for People with Intellectual and Developmental Disabilities across the Lifespan, 631–40. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-18096-0_55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dyson, Simon. "Newborn screening." In Sickle Cell and the Social Sciences, 145–64. Abingdon, Oxon ; New York, NY : Routledge, 2019.: Routledge, 2019. http://dx.doi.org/10.4324/9781315098685-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Frei-Jones, Melissa. "Newborn Screening for Hemoglobinopathies." In Benign Hematologic Disorders in Children, 313–21. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-49980-8_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Heeney, M. M., and R. E. Ware. "Newborn screening for hemoglobinopathies." In Practical Algorithms in Pediatric Hematology and Oncology, 26–27. Basel: KARGER, 2003. http://dx.doi.org/10.1159/000069583.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pasquali, Marzia, and Nicola Longo. "Newborn Screening for Metabolic Disorders." In Molecular Genetics and Personalized Medicine, 163–97. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-61779-530-5_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Urv, Tiina K., and Melissa A. Parisi. "Newborn Screening: Beyond the Spot." In Advances in Experimental Medicine and Biology, 323–46. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-67144-4_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Scott, C. Ronald, Frantisek Turecek, and Michael H. Gelb. "Newborn Screening for Lysosomal Storage Disorders." In Lysosomal Storage Disorders, 169–78. Boston, MA: Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-70909-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Matern, Dietrich, and Piero Rinaldo. "Newborn Screening for Inherited Metabolic Disease." In Inherited Metabolic Diseases, 421–37. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-49410-3_36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wright, Erica. "Newborn Screening for Inherited Metabolic Diseases." In Nutrition Management of Inherited Metabolic Diseases, 23–32. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-94510-7_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rinaldo, Piero, and Dietrich Matern. "Newborn Screening for Inherited Metabolic Disease." In Inherited Metabolic Diseases, 251–61. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-74723-9_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Newborn screening"

1

Lewis-Parmar, Helen, and Jill Walker. "622 Newborn and infant physical examination screening: quality improvement in the English newborn screening pathway." In Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference–Online, 15 June 2021–17 June 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-rcpch.106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gartner, Silvia, Maria J. Alonso, Joan Figuerola, Josep Sirvent, Pedro Mondejar, Carlos Martin, Valle Velasco, et al. "Newborn screening for cystic fibrosis in Spain." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa1265.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wei-Hsin Chen, Han-Ping Chen, Yi-Ju Tseng, Kai-Ping Hsu, Sheau-Ling Hsieh, Yin-Hsiu Chien, Wuh-Liang Hwu, and Feipei Lai. "Newborn Screening for Phenylketonuria: Machine Learning vs Clinicians." In 2012 International Conference on Advances in Social Networks Analysis and Mining (ASONAM 2012). IEEE, 2012. http://dx.doi.org/10.1109/asonam.2012.145.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dafydd, Carwyn, Stuart Moat, Kevin W. Southern, and Iolo J. M. Doull. "Cystic fibrosis newborn screening for R117H in England." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.2762.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Elkhateeb, Nour, Nick Flynn, Sarah Hogg, and Richard Brown. "591 Lessons from the newborn screening for pompe disease: a single-center UK experience based on USA newborn screening program." In Royal College of Paediatrics and Child Health, Abstracts of the RCPCH Conference–Online, 15 June 2021–17 June 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-rcpch.88.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Corona-Strauss, Farah I., Wolfgang Delb, Marc Bloching, Sheikh Hussain, and Daniel J. Strauss. "The Johor Screening Scheme: Is an Area-Wide Newborn Hearing Screening Possible in Malaysia?" In Third International Conference on Intelligent Information Hiding and Multimedia Signal Processing. IEEE, 2007. http://dx.doi.org/10.1109/iih-msp.2007.296.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hazen, Matthew L., and Jonathan Markowitz. "Has Newborn Screening Changed The Initial Presentation Of Cystic Fibrosis?" In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1840.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Parsons, Emily, Katie Teague, Lynne Schaefer, Jacob Hogue, Anjali N. Kunz, and Rebecca J. Sainato. "Congenital CMV Screening in Infants with Failed Newborn Hearing Screens." In AAP National Conference & Exhibition Meeting Abstracts. American Academy of Pediatrics, 2021. http://dx.doi.org/10.1542/peds.147.3_meetingabstract.1033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gharibzadeh Hizal, Mina, Ebru Yalçın, Sanem Eryılmaz, Nagehan Emiralioğlu, Deniz Doğru Ersöz, Uğur Özçelik, and Nural Kiper. "Newborn screening for CF: first tree years experience in Hacettepe University." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa621.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Donovan, B., K. N. Turi, T. Gebretsadik, S. L. Havstad, J. E. Gern, D. J. Jackson, C. Ober, et al. "Identification of Newborn Screening Metabolites and Associated Risk of Infant Bronchiolitis." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1188.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Newborn screening"

1

Whitehead, Nedra, Derek Brown, and Christine Layton. Developing a Conjoint Analysis Survey of Parental Attitudes Regarding Voluntary Newborn Screening. Research Triangle Park, NC: RTI Press, March 2010. http://dx.doi.org/10.3768/rtipress.2010.mr.0014.1002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Whitehead, Nedra, Derek Brown, and Christine Layton. Developing a Conjoint Analysis Survey of Parental Attitudes Regarding Voluntary Newborn Screening. Research Triangle Park, NC: RTI Press, March 2010. http://dx.doi.org/10.3768/rtipress.2010.mr.0014.1003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography